BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15032546)

  • 1. Drug-like annotation and duplicate analysis of a 23-supplier chemical database totalling 2.7 million compounds.
    Baurin N; Baker R; Richardson C; Chen I; Foloppe N; Potter A; Jordan A; Roughley S; Parratt M; Greaney P; Morley D; Hubbard RE
    J Chem Inf Comput Sci; 2004; 44(2):643-51. PubMed ID: 15032546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug- and lead-likeness, target class, and molecular diversity analysis of 7.9 million commercially available organic compounds provided by 29 suppliers.
    Chuprina A; Lukin O; Demoiseaux R; Buzko A; Shivanyuk A
    J Chem Inf Model; 2010 Apr; 50(4):470-9. PubMed ID: 20297844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Data mining a small molecule drug screening representative subset from NIH PubChem.
    Xie XQ; Chen JZ
    J Chem Inf Model; 2008 Mar; 48(3):465-75. PubMed ID: 18302356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collection and preparation of molecular databases for virtual screening.
    Saxena AK; Prathipati P
    SAR QSAR Environ Res; 2006 Aug; 17(4):371-92. PubMed ID: 16920660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the consistency of medicinal chemists in reviewing sets of compounds.
    Lajiness MS; Maggiora GM; Shanmugasundaram V
    J Med Chem; 2004 Sep; 47(20):4891-6. PubMed ID: 15369393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a drug-like natural product library.
    Quinn RJ; Carroll AR; Pham NB; Baron P; Palframan ME; Suraweera L; Pierens GK; Muresan S
    J Nat Prod; 2008 Mar; 71(3):464-8. PubMed ID: 18257534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Representation of chemical information in OASIS centralized 3D database for existing chemicals.
    Nikolov N; Grancharov V; Stoyanova G; Pavlov T; Mekenyan O
    J Chem Inf Model; 2006; 46(6):2537-51. PubMed ID: 17125194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of in silico models for estimating drug preformulation risk in PEG400/water and Tween80/water systems.
    Crivori P; Morelli A; Pezzetta D; Rocchetti M; Poggesi I
    Eur J Pharm Sci; 2007 Nov; 32(3):169-81. PubMed ID: 17714921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADME evaluation in drug discovery. 5. Correlation of Caco-2 permeation with simple molecular properties.
    Hou TJ; Zhang W; Xia K; Qiao XB; Xu XJ
    J Chem Inf Comput Sci; 2004; 44(5):1585-600. PubMed ID: 15446816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global and local computational models for aqueous solubility prediction of drug-like molecules.
    Bergström CA; Wassvik CM; Norinder U; Luthman K; Artursson P
    J Chem Inf Comput Sci; 2004; 44(4):1477-88. PubMed ID: 15272856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and characterization of libraries of molecular fragments for use in NMR screening against protein targets.
    Baurin N; Aboul-Ela F; Barril X; Davis B; Drysdale M; Dymock B; Finch H; Fromont C; Richardson C; Simmonite H; Hubbard RE
    J Chem Inf Comput Sci; 2004; 44(6):2157-66. PubMed ID: 15554686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A screening study of ChirBase molecular database to explore the expanded chiral pool derived from the application of chiral chromatography.
    Piras P; Roussel C
    J Pharm Biomed Anal; 2008 Apr; 46(5):839-47. PubMed ID: 17942261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virtual screening and scaffold hopping based on GRID molecular interaction fields.
    Ahlström MM; Ridderström M; Luthman K; Zamora I
    J Chem Inf Model; 2005; 45(5):1313-23. PubMed ID: 16180908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new rapid and effective chemistry space filter in recognizing a druglike database.
    Zheng S; Luo X; Chen G; Zhu W; Shen J; Chen K; Jiang H
    J Chem Inf Model; 2005; 45(4):856-62. PubMed ID: 16045278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large-scale annotation of small-molecule libraries using public databases.
    Zhou Y; Zhou B; Chen K; Yan SF; King FJ; Jiang S; Winzeler EA
    J Chem Inf Model; 2007; 47(4):1386-94. PubMed ID: 17608408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncology exploration: charting cancer medicinal chemistry space.
    Lloyd DG; Golfis G; Knox AJ; Fayne D; Meegan MJ; Oprea TI
    Drug Discov Today; 2006 Feb; 11(3-4):149-59. PubMed ID: 16533713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the scaffold diversity of screening libraries.
    Krier M; Bret G; Rognan D
    J Chem Inf Model; 2006; 46(2):512-24. PubMed ID: 16562979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New QSPR study for the prediction of aqueous solubility of drug-like compounds.
    Duchowicz PR; Talevi A; Bruno-Blanch LE; Castro EA
    Bioorg Med Chem; 2008 Sep; 16(17):7944-55. PubMed ID: 18701302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimation of pKa for druglike compounds using semiempirical and information-based descriptors.
    Jelfs S; Ertl P; Selzer P
    J Chem Inf Model; 2007; 47(2):450-9. PubMed ID: 17381168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sharing chemical information without sharing chemical structure.
    Masek BB; Shen L; Smith KM; Pearlman RS
    J Chem Inf Model; 2008 Feb; 48(2):256-61. PubMed ID: 18254609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.